PATENT CLAIM ANALYSIS

Application Number: 15886249
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "217040"]

Abstract:
This invention relates to compounds that are agonists of the muscarinic M1 receptor and which are useful in the treatment of muscarinic M1 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula I, where n is 1 or 2; p is 0, 1 or 2; q is 0, 1 or 2; and R 1 -R 6  are as defined herein.

Claim (Index 24):
The compound according to  claim 22  which is ethyl (4S)-4-[4-((2-methylpropyl)methylcarbamoyl)piperidin-1-yl]azepane-1-carboxylate, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.72917
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14358984', '14941328', '15595107', '14428927', '14996829']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8547547963949719
- 35 USC 102 Novelty (BERT): 0.6460133967738846
- Combined Prediction Score: 0.8338806564328631
- Mean Citation Score: 557.1527319999999
- Max Citation Score: 680.64044
- Similarity Product: 571.8734533171918

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test